Health and Wellness
The G7 continuous glucose monitoring system will have a 15.5-day wear time and last 15% longer than Dexcom G7, according to the company.
The study has demonstrated the potential of predictable movement stimuli as a behavioural marker of autism spectrum disorder.
A study published in the European Journal of Cancer says inaccurate results and misdiagnoses could occur if diverse populations are not included in clinical research.
The company will use the funds to grow its provider base and expand to Ohio.
The partnership is focused on modernizing the measurement, proof and financial effect of social determinants of health interventions.
In January, Transcarent announced it was acquiring Accolade and taking it private.
The research initiative aims to enhance the Galaxy Watch’s sleep apnea detection feature and ultimately create AI-powered tools for proactive sleep health management.
The alliance allows Flatiron Health to use Massive Bio's database to match oncology patients to clinical trials within their proximity.
The acquisition brings the parties' cross-litigation alleging patent infringements to a close.
Lark's cardiometabolic care coaching programs will be made accessible through CVS Caremark's Point Solutions Management program.